Cargando…
Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy
PURPOSE/OBJECTIVE: Little is known about the clinical impact of using multiparametric MRI to plan early salvage radiotherapy after radical prostatectomy. We aimed to evaluate the incidence and location of recurrence based on pelvic multiparametric MRI findings and to identify clinical variables pred...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690270/ https://www.ncbi.nlm.nih.gov/pubmed/26704623 http://dx.doi.org/10.1186/s13014-015-0574-6 |
_version_ | 1782406982866567168 |
---|---|
author | Hernandez, D. Salas, D. Giménez, D. Buitrago, P. Esquena, S. Palou, J. de la Torre, P. Pernas, J. Gich, I. de Segura, G. Gómez Craven-Bartle, J. Sancho, G. |
author_facet | Hernandez, D. Salas, D. Giménez, D. Buitrago, P. Esquena, S. Palou, J. de la Torre, P. Pernas, J. Gich, I. de Segura, G. Gómez Craven-Bartle, J. Sancho, G. |
author_sort | Hernandez, D. |
collection | PubMed |
description | PURPOSE/OBJECTIVE: Little is known about the clinical impact of using multiparametric MRI to plan early salvage radiotherapy after radical prostatectomy. We aimed to evaluate the incidence and location of recurrence based on pelvic multiparametric MRI findings and to identify clinical variables predictive of positive imaging results. MATERIALS AND METHODS: We defined radiological criteria of local and lymph node malignancy and reviewed records and MRI studies of 70 patients with PSA recurrence after radical prostatectomy. We performed univariate and multivariate analysis to identify any association between clinical, pathological and treatment-related variables and imaging results. RESULTS: Multiparametric MRI was positive in 33/70 patients. We found local and lymph node recurrence in 27 patients and 7 patients, respectively, with a median PSA value of 0.38 ng/ml. We found no statistically significant differences between patients with positive and negative multiparametric MRI for any variable. Shorter PSADT was associated with positive lymph nodes (median PSADT: 5.12 vs 12.70 months; p: 0.017). CONCLUSIONS: Nearly half the patients had visible disease in multiparametric MRI despite low PSA. Positive lymph nodes incidence should be considered when planning salvage radiotherapy, particularly in patients with a short PSADT. |
format | Online Article Text |
id | pubmed-4690270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46902702015-12-25 Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy Hernandez, D. Salas, D. Giménez, D. Buitrago, P. Esquena, S. Palou, J. de la Torre, P. Pernas, J. Gich, I. de Segura, G. Gómez Craven-Bartle, J. Sancho, G. Radiat Oncol Research PURPOSE/OBJECTIVE: Little is known about the clinical impact of using multiparametric MRI to plan early salvage radiotherapy after radical prostatectomy. We aimed to evaluate the incidence and location of recurrence based on pelvic multiparametric MRI findings and to identify clinical variables predictive of positive imaging results. MATERIALS AND METHODS: We defined radiological criteria of local and lymph node malignancy and reviewed records and MRI studies of 70 patients with PSA recurrence after radical prostatectomy. We performed univariate and multivariate analysis to identify any association between clinical, pathological and treatment-related variables and imaging results. RESULTS: Multiparametric MRI was positive in 33/70 patients. We found local and lymph node recurrence in 27 patients and 7 patients, respectively, with a median PSA value of 0.38 ng/ml. We found no statistically significant differences between patients with positive and negative multiparametric MRI for any variable. Shorter PSADT was associated with positive lymph nodes (median PSADT: 5.12 vs 12.70 months; p: 0.017). CONCLUSIONS: Nearly half the patients had visible disease in multiparametric MRI despite low PSA. Positive lymph nodes incidence should be considered when planning salvage radiotherapy, particularly in patients with a short PSADT. BioMed Central 2015-12-24 /pmc/articles/PMC4690270/ /pubmed/26704623 http://dx.doi.org/10.1186/s13014-015-0574-6 Text en © Hernandez et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hernandez, D. Salas, D. Giménez, D. Buitrago, P. Esquena, S. Palou, J. de la Torre, P. Pernas, J. Gich, I. de Segura, G. Gómez Craven-Bartle, J. Sancho, G. Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
title | Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
title_full | Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
title_fullStr | Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
title_full_unstemmed | Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
title_short | Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy |
title_sort | pelvic mri findings in relapsed prostate cancer after radical prostatectomy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690270/ https://www.ncbi.nlm.nih.gov/pubmed/26704623 http://dx.doi.org/10.1186/s13014-015-0574-6 |
work_keys_str_mv | AT hernandezd pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT salasd pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT gimenezd pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT buitragop pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT esquenas pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT palouj pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT delatorrep pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT pernasj pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT gichi pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT deseguraggomez pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT cravenbartlej pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy AT sanchog pelvicmrifindingsinrelapsedprostatecancerafterradicalprostatectomy |